| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $243.7M | -22.0% |
| Cost of Revenue | $69.4M | -25.7% |
| R&D Expense | $54.7M | -45.2% |
| SG&A Expense | $44.4M | -44.5% |
| Operating Income | -$78.7M | +57.0% |
| Interest Expense | $31.5M | +117.7% |
| Income Tax | $3.5M | +26.2% |
| Net Income | -$67.2M | +49.9% |
| EPS (Basic) | -$8.57 | -467.5% |
| EPS (Diluted) | -$12.39 | -720.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $95.0M | -48.2% |
| Accounts Receivable | $27.0M | -6.0% |
| Current Assets | $137.1M | -40.7% |
| Total Assets | $454.7M | -25.2% |
| Current Liabilities | $122.6M | -12.4% |
| Total Liabilities | $499.2M | -26.1% |
| Stockholders' Equity | -$44.5M | +33.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$30.4M | -101.2% |
| Capital Expenditures | $12.1M | -51.9% |
| Investing Cash Flow | -$13.7M | +51.4% |
| Financing Cash Flow | -$45.5M | -403.9% |
| Free Cash Flow | -$42.5M | -5.6% |